Colon Cancer Home > Camptosar Warnings and Precautions
You may need to have a certain genetic test before undergoing treatment with Camptosar to see if you are at risk for potentially serious reactions. People receiving this chemotherapy drug may also experience anemia, infections, or bleeding. Other safety precautions with Camptosar involve understanding the warnings of potential drug interactions. Risks with this drug also apply to women who are pregnant or breastfeeding.
What Should I Tell My Healthcare Provider?Talk with your healthcare provider prior to receiving Camptosar® (irinotecan) if you have:
- Any infection
- Kidney disease, such as kidney failure (renal failure)
- Liver disease, such as hepatitis, cirrhosis, or liver failure
- Lung disease, such as asthma or chronic obstructive pulmonary disease (COPD)
- Heart disease or had a recent heart attack
- Plans to receive a vaccination
- Bone marrow problems
- Gilbert's syndrome (a decreased ability to break down bilirubin)
- A hereditary inability to digest fructose (a type of sugar found in fruit)
- Received radiation treatment to your pelvic or abdominal (stomach) area
- A bowel obstruction (intestinal blockage), inflammation (colitis), or constipation
- Any allergies, including to foods, dyes, or preservatives.
Also, let your healthcare provider know if you are:
- Pregnant or thinking of becoming pregnant.
You should also tell your healthcare provider about all other medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.